Life Science Investing Tenax Therapeutics Announces European Patent Office Intention to Grant Patent Covering Use of Levosimendan in PH-HFpEF 16 September
Life Science Investing Tenax Therapeutics to Participate in the Cantor Global Healthcare Conference 2025 28 August
Life Science Investing Tenax Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update 13 August
